{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:15:37Z","timestamp":1790853337071,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00436","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T05:02:44Z","timestamp":1338526964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":170,"title":["Explicit hypoxia targeting with tumor suppression by creating an \u201cobligate\u201d anaerobic Salmonella Typhimurium strain"],"prefix":"10.1038","volume":"2","author":[{"given":"Bin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Han","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,1]]},"reference":[{"key":"BFsrep00436_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","volume":"4","author":"JM Brown","year":"2004","unstructured":"Brown, J. M. & Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4, 437\u2013447 (2004).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep00436_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2005.05.028","volume":"237","author":"J Zhou","year":"2006","unstructured":"Zhou, J., Schmid, T., Schnitzer, S. & Brune, B. Tumor hypoxia and cancer progression. Cancer Lett 237, 10\u201321 (2006).","journal-title":"Cancer Lett"},{"key":"BFsrep00436_CR3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1470-2045(03)01194-X","volume":"4","author":"J Pawelek","year":"2003","unstructured":"Pawelek, J., Low, K. & Bermudes, D. Bacteria as tumour-targeting vectors. Lancet Oncol 4, 548\u2013556 (2003).","journal-title":"Lancet Oncol"},{"key":"BFsrep00436_CR4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.copbio.2008.08.004","volume":"19","author":"AT St Jean","year":"2008","unstructured":"St Jean, A. T., Zhang, M. & Forbes, N. S. Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol 19, 511\u2013517 (2008).","journal-title":"Curr Opin Biotechnol"},{"key":"BFsrep00436_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/bit.20883","volume":"94","author":"RW Kasinskas","year":"2006","unstructured":"Kasinskas, R. W. & Forbes, N. S. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 94, 710\u2013721 (2006).","journal-title":"Biotechnol Bioeng"},{"key":"BFsrep00436_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-6-8","volume":"6","author":"MQ Wei","year":"2008","unstructured":"Wei, M. Q., Ren, R., Good, D. & Anne, J. Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems. Genet Vaccines Ther 6, 8 (2008).","journal-title":"Genet Vaccines Ther"},{"key":"BFsrep00436_CR7","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1073\/pnas.0803801105","volume":"105","author":"W Kong","year":"2008","unstructured":"Kong, W. et al. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. PNAS 105, 9361\u20139366 (2008).","journal-title":"PNAS"},{"key":"BFsrep00436_CR8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejca.2006.10.005","volume":"43","author":"MQ Wei","year":"2007","unstructured":"Wei, M. Q. et al. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours. Eur J Cancer 43, 490\u2013496 (2007).","journal-title":"Eur J Cancer"},{"key":"BFsrep00436_CR9","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","volume":"98","author":"LH Dang","year":"2001","unstructured":"Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W. & Vogelstein, B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 98, 15155\u201315160 (2001).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep00436_CR10","unstructured":"Hall, S. S. A commotion in the blood : life, death and the immune system, Edn. 1st. (Henry Holt, New York, 1997)."},{"key":"BFsrep00436_CR11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00109-010-0636-z","volume":"88","author":"S Leschner","year":"2010","unstructured":"Leschner, S. & Weiss, S. Salmonella-allies in the fight against cancer. J Mol Med 88, 763\u2013773 (2010).","journal-title":"J Mol Med"},{"key":"BFsrep00436_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1349-7006.2006.00221.x","volume":"97","author":"T Sasaki","year":"2006","unstructured":"Sasaki, T. et al. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci 97, 649\u2013657 (2006).","journal-title":"Cancer Sci"},{"key":"BFsrep00436_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.cgt.7700122","volume":"7","author":"K Yazawa","year":"2000","unstructured":"Yazawa, K., Fujimori, M., Amano, J., Kano, Y. & Taniguchi, S. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther 7, 269\u2013274 (2000).","journal-title":"Cancer Gene Ther"},{"key":"BFsrep00436_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1010644217648","volume":"66","author":"K Yazawa","year":"2001","unstructured":"Yazawa, K. et al. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat 66, 165\u2013170 (2001).","journal-title":"Breast Cancer Res Treat"},{"key":"BFsrep00436_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2672.2006.02886.x","volume":"101","author":"S Barbe","year":"2006","unstructured":"Barbe, S., Van Mellaert, L. & Anne, J. The use of clostridial spores for cancer treatment. J Appl Microbiol 101, 571\u2013578 (2006).","journal-title":"J Appl Microbiol"},{"key":"BFsrep00436_CR16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tim.2006.02.002","volume":"14","author":"L Van Mellaert","year":"2006","unstructured":"Van Mellaert, L., Barbe, S. & Anne, J. Clostridium spores as anti-tumour agents. Trends Microbiol 14, 190\u2013196 (2006).","journal-title":"Trends Microbiol"},{"key":"BFsrep00436_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.gt.3301659","volume":"9","author":"SC Liu","year":"2002","unstructured":"Liu, S. C., Minton, N. P., Giaccia, A. J. & Brown, J. M. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis. Gene Ther 9, 291\u2013296 (2002).","journal-title":"Gene Ther"},{"key":"BFsrep00436_CR18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/sj.bjc.6603367","volume":"95","author":"J Theys","year":"2006","unstructured":"Theys, J. et al. Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer 95, 1212\u20131219 (2006).","journal-title":"Br J Cancer"},{"key":"BFsrep00436_CR19","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1158\/0008-5472.CAN-08-1698","volume":"68","author":"SC Liu","year":"2008","unstructured":"Liu, S. C. et al. Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104. Cancer Res 68, 7995\u20138003 (2008).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR20","first-page":"4537","volume":"57","author":"JM Pawelek","year":"1997","unstructured":"Pawelek, J. M., Low, K. B. & Bermudes, D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57, 4537\u20134544 (1997).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR21","first-page":"37","volume":"17","author":"KB Low","year":"1999","unstructured":"Low, K. B. et al. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 17, 37\u201341 (1999).","journal-title":"Nat Biotechnol"},{"key":"BFsrep00436_CR22","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1158\/0008-5472.CAN-06-2618","volume":"67","author":"RW Kasinskas","year":"2007","unstructured":"Kasinskas, R. W. & Forbes, N. S. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 67, 3201\u20133209 (2007).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-09-3453","volume":"70","author":"VH Nguyen","year":"2010","unstructured":"Nguyen, V. H. et al. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 70, 18\u201323 (2010).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR24","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-06-0716","volume":"66","author":"M Zhao","year":"2006","unstructured":"Zhao, M. et al. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66, 7647\u20137652 (2006).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jcb.22078","volume":"106","author":"K Hayashi","year":"2009","unstructured":"Hayashi, K. et al. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 106, 992\u2013998 (2009).","journal-title":"J Cell Biochem"},{"key":"BFsrep00436_CR26","unstructured":"Yam, C. et al. Monotherapy with a Tumor-Targeting Mutant of S. typhimurium Inhibits Liver Metastasis in a Mouse Model of Pancreatic Cancer. J Surg Res (2009)."},{"key":"BFsrep00436_CR27","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1073\/pnas.0703867104","volume":"104","author":"M Zhao","year":"2007","unstructured":"Zhao, M. et al. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A 104, 10170\u201310174 (2007).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep00436_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/291238a0","volume":"291","author":"SK Hoiseth","year":"1981","unstructured":"Hoiseth, S. K. & Stocker, B. A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238\u2013239 (1981).","journal-title":"Nature"},{"key":"BFsrep00436_CR29","first-page":"5188","volume":"63","author":"NS Forbes","year":"2003","unstructured":"Forbes, N. S., Munn, L. L., Fukumura, D. & Jain, R. K. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 63, 5188\u20135193 (2003).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR30","doi-asserted-by":"crossref","first-page":"e6692","DOI":"10.1371\/journal.pone.0006692","volume":"4","author":"S Leschner","year":"2009","unstructured":"Leschner, S. et al. Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 4, e6692 (2009).","journal-title":"PLoS One"},{"key":"BFsrep00436_CR31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1462-5822.2007.00890.x","volume":"9","author":"H Loessner","year":"2007","unstructured":"Loessner, H. et al. Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 9, 1529\u20131537 (2007).","journal-title":"Cell Microbiol"},{"key":"BFsrep00436_CR32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nmeth1107","volume":"4","author":"JL Royo","year":"2007","unstructured":"Royo, J. L. et al. In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods 4, 937\u2013942 (2007).","journal-title":"Nat Methods"},{"key":"BFsrep00436_CR33","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-07-2984","volume":"68","author":"K Westphal","year":"2008","unstructured":"Westphal, K., Leschner, S., Jablonska, J., Loessner, H. & Weiss, S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68, 2952\u20132960 (2008).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR34","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","volume":"181","author":"C Clairmont","year":"2000","unstructured":"Clairmont, C. et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 181, 1996\u20132002 (2000).","journal-title":"J Infect Dis"},{"key":"BFsrep00436_CR35","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-07-4800","volume":"14","author":"F Friedlos","year":"2008","unstructured":"Friedlos, F. et al. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy. Clin Cancer Res 14, 4259\u20134266 (2008).","journal-title":"Clin Cancer Res"},{"key":"BFsrep00436_CR36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1349-7006.2007.00503.x","volume":"98","author":"LJ Jia","year":"2007","unstructured":"Jia, L. J. et al. Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models. Cancer Sci 98, 1107\u20131112 (2007).","journal-title":"Cancer Sci"},{"key":"BFsrep00436_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002371-200303000-00011","volume":"26","author":"DM Heimann","year":"2003","unstructured":"Heimann, D. M. & Rosenberg, S. A. Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma. J Immunother 26, 179\u2013180 (2003).","journal-title":"J Immunother"},{"key":"BFsrep00436_CR38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20, 142\u2013152 (2002).","journal-title":"J Clin Oncol"},{"key":"BFsrep00436_CR39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","volume":"102","author":"M Zhao","year":"2005","unstructured":"Zhao, M. et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 102, 755\u2013760 (2005).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep00436_CR40","doi-asserted-by":"crossref","first-page":"34183","DOI":"10.1074\/jbc.M313491200","volume":"279","author":"M Song","year":"2004","unstructured":"Song, M. et al. ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 279, 34183\u201334190 (2004).","journal-title":"J Biol Chem"},{"key":"BFsrep00436_CR41","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1158\/0008-5472.CAN-09-4005","volume":"70","author":"N Arrach","year":"2010","unstructured":"Arrach, N. et al. High-throughput screening for salmonella avirulent mutants that retain targeting of solid tumors. Cancer Res 70, 2165\u20132170 (2010).","journal-title":"Cancer Res"},{"key":"BFsrep00436_CR42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/ja077455+","volume":"130","author":"J Crack","year":"2008","unstructured":"Crack, J. et al. Influence of the Environment on the [4Fe-4S]2+ to [2Fe-2S]2+ Cluster Switch in the Transcriptional Regulator FNR. J. AM. CHEM. SOC. 130, 1749\u20131758 (2008).","journal-title":"J. AM. CHEM. SOC."},{"key":"BFsrep00436_CR43","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4161\/cbt.5.9.2951","volume":"5","author":"A Mengesha","year":"2006","unstructured":"Mengesha, A. et al. Development of a Flexible and Potent Hypoxia-Inducible Promoter for Tumor-Targeted Gene Expression in Attenuated Salmonella. Cancer Biology & Therapy 5, 1120\u20131128 (2006).","journal-title":"Cancer Biology & Therapy"},{"key":"BFsrep00436_CR44","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1074\/jbc.M109.089755","volume":"285","author":"A Boysen","year":"2010","unstructured":"Boysen, A., Moller-Jensen, J., Kallipolitis, B., Valentin-Hansen, P. & Overgaard, M. Translational regulation of gene expression by an anaerobically induced small non-coding RNA in Escherichia coli. J Biol Chem 285, 10690\u201310702 (2010).","journal-title":"J Biol Chem"},{"key":"BFsrep00436_CR45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0958-1669(00)00132-4","volume":"11","author":"PB Rainey","year":"2000","unstructured":"Rainey, P. B. & Preston, G. M. In vivo expression technology strategies: valuable tools for biotechnology. Curr Opin Biotechnol 11, 440\u2013444 (2000).","journal-title":"Curr Opin Biotechnol"},{"key":"BFsrep00436_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mimet.2009.10.018","volume":"80","author":"JT Heap","year":"2010","unstructured":"Heap, J. T. et al. The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods 80, 49\u201355 (2010).","journal-title":"J Microbiol Methods"},{"key":"BFsrep00436_CR47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00253-011-3317-0","volume":"91","author":"B Yu","year":"2011","unstructured":"Yu, B. et al. A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy. Appl Microbiol Biotechnol 91, 177\u2013188 (2011).","journal-title":"Appl Microbiol Biotechnol"},{"key":"BFsrep00436_CR48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2006.04.018","volume":"379","author":"S Datta","year":"2006","unstructured":"Datta, S., Costantino, N. & Court, D. L. A set of recombineering plasmids for gram-negative bacteria. Gene 379, 109\u2013115 (2006).","journal-title":"Gene"},{"key":"BFsrep00436_CR49","unstructured":"Animal Research Advisory Committee. Guidelines for Endpoints in Animal Study Proposals. http:\/\/oacu.od.nih.gov\/ARAC\/documents\/ASP_Endpoints.pdf (2011)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00436","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:25:58Z","timestamp":1672961158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,12,21]]}},"alternative-id":["BFsrep00436"],"URL":"https:\/\/doi.org\/10.1038\/srep00436","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,1]]},"assertion":[{"value":"1 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}